China’s most innovation-forward city just made its clearest commitment yet to the future of stem cell and gene therapy. Shenzhen recently released the official outline of its 15th Five-Year Plan for National Economic and Social Development, and for anyone following the cell therapy space, the language is striking. Cells and genes have been designated as … Read more
On April 28, 2026, the 2025 Forbes China ESG Image Enterprise Figures Summit and Awards Ceremony concluded in a landmark gathering that brought together over 500 global dignitaries, diplomatic envoys, and industry leaders from across the world. Among those honored was Dr. Hu Junyuan, founder and chairman of Beike Biotechnology, who received the distinguished title … Read more
Two of Asia’s most prominent names in regenerative medicine and clinical research are joining forces with a shared mission to bring advanced stem cell treatments to patients with autoimmune disease, type 2 diabetes, and other intractable conditions. On May 11, 2026, Dr. Hu Junyuan, founder and chairman of Shenzhen Beike Biotechnology, and Academician Wei Yuquan of … Read more